Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Dr. Jean-Pierre Bizzari

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Dec 14, 2023 3:53pm

163 Views

Post# 35785363

RE:RE:RE:RE:RE:Dr. Jean-Pierre Bizzari

Euggh. Have you read who this guy is and what he's done? He's now involved with our company. Read our advisor and director list then spend a minute investigating who they are and what they've achieved.

You dopes want to win the lottery.... buy a ticket and wait for your numbers to be called.

People, right now all over the world, are dying in their thousands from war, illness and starvation. Count your blessing, shut up amd wait. Or go away.

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets